Rhythm Pharmaceuticals, Inc. RYTM
112.16 USD -1.79 (-1.57%)
At closeNov 11, 2026, 5:25 PM EST
112.16 0.00 0.00%
After hours · Nov 11, 5:25 PM ET
112.04 Day range 115.20
74.50 52-week range 122.20
- YTD
- +4.78%
- 1 year
- +12.32%
RYTM revenue history
Revenue is income from the company’s ordinary business activities.
189,757,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 189,757,000 | 59,631,000 | 45.83% |
| FY 2024 | 2024-12-31 | 130,126,000 | 52,698,000 | 68.06% |
| FY 2023 | 2023-12-31 | 77,428,000 | 53,790,000 | 227.56% |
| FY 2022 | 2022-12-31 | 23,638,000 | 20,484,000 | 649.46% |
| FY 2021 | 2021-12-31 | 3,154,000 | 3,154,000 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | 0 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | 0 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-11-05T07:00:38.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.